Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prazosin add-on treatment for obsessive-compulsive disorder
NL-OMON32256Phase 2Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of prazosin in obsessive compulsive disorder (OCD), sponsored by Amsterdam University Medical Center. Primary endpoints: Change in Yale-Brown Obsessive Compulsive Scale and Number of responders. Planned start Mar 2008; status: not yet recruiting.
02
Drugs
prazosin
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NL-OMON32256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32256.